Keywords: Biomarkers, Cancer, ferumoxytol, tumor microvasculature, tumor associated macrophages
Motivation: To develop a noninvasive MRI based approach for monitoring the tumor microenvironment (TME).
Goal(s): To assess changes in vascular volume fraction (VVF) and tumor associated macrophages (TAM) as measures of TME.
Approach: We measured VVF and TAM (by changes in T2 and T2*) at baseline and following therapy using ferumoxytol in a murine model of pancreatic cancer (PDAC). We performed a preclinical trial with an immune modulatory agent.
Results: We saw a statistically significant difference in tumor growth and changes of VVF and TAM with immune modulation.
Impact: We have developed a method of monitoring the PDAC TME with possibilities of human translation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords